Board and Investors



  • KIKK Capital - lead investor

  • OostNL

  • RVO


Jos Joore

Chairman of the Board, co-founder

Jos is a biotech entrepreneur with over 20 years of executive level bio-business experience in companies including Mimetas, Pepscan, SkylineDx, Kreatech Diagnostics (now part of Leica Biosystems ) and Westburg. He is a co-founder of Pepscope and CEO and co-founder of Mimetas, raising over €30 million in funding. As a scientist, he studied vertebrate embryonal axis formation and brain development at the Hubrecht Institute (Utrecht, NL) and King’s College (London, UK). He has published over 50 scientific papers and patents. Jos holds a cum laude master’s degree in business marketing, a master’s degree in biology and a Ph.D. in developmental biology.


Hans Brouwer

Non-Executive Board Member, co-founder

Hans studied Applied Physics at Delft University of Technology, graduating (Ir.) in 1982. After working for Philips, ASMI NV and European Silicon Structures Ltd, a high tech semiconductor company, he started his first business, CPS Europe, developing electronic products in 1993. He is a co-founder of Pepscope, founder of Omniradar and Optics11 and holds several patents.


Anna Ressa

Executive Board Member, CEO, co-founder

Anna is a pragmatic leader and team player with longstanding experience in proteomics. She joined Pepscope in 2018 as Scientific Lead in mass spectrometry, bringing over eight years of experience in academic and industrial R&D, including Nerviano Medical Sciences. In 2018, Anna took the initiative for a strategic partnership between Pepscope and Utrecht University, resulting in the adoption of QuantaKinome technology. She has led the Pepscope team since 2019, culminating in accepting a position as CEO in 2020. This appointment coincided with the completion of a successful investment of €4.3 million, in which she played a crucial role. Anna obtained her Ph.D. at the Utrecht University in the Biomolecular Mass Spectrometry & Proteomics group, has a cum laude M.Sc. in Chemistry from the University of Bologna, and a degree in Cancer Pharmacology from the University of Milan.


Johan Sebregts

Non-Executive Board Member, investor



Thomas Hensel

Non-Executive Board Member, investor